Try our Advanced Search for more refined results

Expert Analysis

Orthofix, Pfizer FCPA Cases A Sign Of What's To Come

Law360, New York (September 21, 2012, 1:14 PM EDT) -- In November 2009, Lanny Breuer, assistant attorney general for the U.S. Department of Justice's Criminal Division, publicly announced that the DOJ intended to focus on U.S. Foreign Corrupt Practices Act violations in the pharmaceutical and medical device industries.[1] According to the DOJ, "The depth of government involvement in foreign health systems, combined with fierce industry competition and the closed nature of many public formularies, creates, in our view, a significant risk that corrupt payments will infect the process."[2] ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!